Archives for September 2008
Skin Virus Spreads In Rugby Players And Sumo Wrestlers
Rugby players may get more than just the ball out of a scrum - herpes virus can cause a skin disease called “scrumpox” and it spreads through physical contact. Researchers have studied the spread of the disease among sumo wrestlers in Japan and have discovered that a new strain of the virus could [...]
Synvista Therapeutics Receives Approval To Begin Phase 2 Trial Of Topical SYI-2074 In Psoriasis
Synvista Therapeutics, Inc. (Amex: SYI) announces that it has received approval from the Israeli Ministry of Health to begin a Phase 2 trial of a topical formulation of SYI-2074 in mild-to-moderate plaque psoriasis. The trial is [...]
Melanoma Research Included In 2009 Defense Appropriations, USA
The Department of Defense is seeking $4 million dedicated to research efforts on melanoma and other skin cancers, a danger facing many military personnel. As part of the Fiscal 2009 Department of Defense Appropriations Conference Report, the House of Representatives is currently considering the measure.
Original post by Dermatology News From Medical News Today
Patient Focus As A Key Success Factor In The Treatment Of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects many children and adults, often significantly compromising their quality of life. Treatment success, therefore, should be considered not only from a clinical point of view but also from the patient’s perspective.
Original post by Dermatology News From Medical News Today
Delcath Adds Providence Cancer Center To Phase III Trial - Robert W. Franz Cancer Research Center Is 2nd West Coast Center
Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Robert W. Franz Cancer Research Center, a part of the Providence Cancer Center, located in Portland, Oregon, has joined Delcath’s Phase III clinical trial for the treatment of inoperable metastatic [...]
Fishy Diet In Early Infancy Cuts Eczema Risk
An infant diet that includes fish before the age of 9 months curbs the risk of developing eczema, indicates research published ahead of print in the Archives of Disease in Childhood. The prevalence of atopic eczema and other allergic disease has risen sharply in developed countries in recent decades, say the authors. [...]
Arpida Completes Enrolment In Phase II “Intravenous-to-Oral” Switch Trial With Oral Iclaprim
Arpida’s leading product candidate is intravenous iclaprim, a potent antibacterial that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). The clinical programme for the first indication, complicated skin and skin structure infections (cSSSI), has been completed. The submission [...]
Dyax Announces Completion Of Biologics License Application For DX-88 for Hereditary Angioedema
Dyax Corp.(NASDAQ:DYAX) announced the completion of its Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of Dyax’s lead product candidate DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE). Dyax has requested Priority Review, which, if granted, would set a target date of six months from receipt of the [...]
Pilot Study Of Wellstar’s Thermal Imaging Device Completed By Duke University Medical Center
Wellstar International, Inc. (OTCBB: WLSI), a developer of thermal imaging, diagnostic software and equipment, announced today that an important, pilot evaluation of the Company’s TMI infrared thermal imaging device has been completed by Duke University Medical Center. The device [...]
Skin Disorder Vitiligo Could Yield Clues In Fight Against Melanoma
About 1 million Americans suffer a skin disorder called vitiligo, which causes unsightly white patches on the face, hands and other parts of the body. A Loyola University Hospital researcher has won a five-year, $1.7 million federal grant to investigate a new way to treat vitiligo. This research also could point the [...]